Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1208/s12249-014-0114-y http://scihub22266oqcxt.onion/10.1208/s12249-014-0114-y C4113625!4113625!24728868     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       AAPS+PharmSciTech 2014 ; 15 (4): 882-97 Nephropedia Template TP {{tp|p=24728868|t=2014. Advances in Device and Formulation Technologies for Pulmonary Drug Delivery |pdf=|usr=}}{{24728868}} gab.com Text Advances in Device and Formulation Technologies for Pulmonary Drug Delivery JO: AAPS PharmSciTech http://www.kidney.de/pget.php?&tw=1&pmid=24728868 #FOAvip Inhaled pharmaceuticals are formulated and delivered differently according to the therapeutic indication. However, specific device-formulation coupling is often fickle, and new medications or indications also demand new strategies. The discontinuation of chlorofluorocarbon propellants has seen replacement of older metered dose inhalers with dry powder inhaler formulations. High-dose dry powder inhalers are increasingly seen as an alternative dosage form for nebulised medications. In other cases, new medications have completely bypassed conventional inhalers and been formulated for use with unique inhalers such as the Staccato® device. Among these different devices, integration of software and electronic assistance has become a shared trend. This review covers recent device and formulation advances that are forming the current landscape of inhaled therapeutics. Twit Text FOAVip Advances in Device and Formulation Technologies for Pulmonary Drug Delivery ????AAPS PharmSciTech http://www.kidney.de/pget.php?&tw=1&pmid=24728868 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=24728868 #FOAvip English Wikipedia <ref>{{Cite pmid|24728868}}</ref> Advances in Device and Formulation Technologies for Pulmonary Drug Delivery #MMPMID24728868 Chan JGY; Wong J; Zhou QT; Leung SSY; Chan HK AAPS PharmSciTech 2014[Aug]; 15 (4): 882-97 PMID24728868show ga Inhaled pharmaceuticals are formulated and delivered differently according to the therapeutic indication. However, specific device-formulation coupling is often fickle, and new medications or indications also demand new strategies. The discontinuation of chlorofluorocarbon propellants has seen replacement of older metered dose inhalers with dry powder inhaler formulations. High-dose dry powder inhalers are increasingly seen as an alternative dosage form for nebulised medications. In other cases, new medications have completely bypassed conventional inhalers and been formulated for use with unique inhalers such as the Staccato® device. Among these different devices, integration of software and electronic assistance has become a shared trend. This review covers recent device and formulation advances that are forming the current landscape of inhaled therapeutics. äAdvances in Device and Formulation Technologies for Pulmonary Drug Del(epmc).pdf DeepDyve Pubget Overpricing